0002081008-26-000002.txt : 20261019 0002081008-26-000002.hdr.sgml : 20261019 20261016174837 ACCESSION NUMBER: 0002081008-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261019 DATE AS OF CHANGE: 20261016 EFFECTIVENESS DATE: 20261019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Precision IO Group Inc. CENTRAL INDEX KEY: 0002081008 ORGANIZATION NAME: EIN: 873021504 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-601638 FILM NUMBER: 261467154 BUSINESS ADDRESS: STREET 1: 9905 NW 17TH STREET STREET 2: BUILDING 1 CITY: MIAMI STATE: FL ZIP: 33172 BUSINESS PHONE: 305-913-2400 MAIL ADDRESS: STREET 1: 9905 NW 17TH STREET STREET 2: BUILDING 1 CITY: MIAMI STATE: FL ZIP: 33172 FORMER COMPANY: FORMER CONFORMED NAME: Quantum Surgical Inc DATE OF NAME CHANGE: 20250811 D 1 primary_doc.xml X0708 D LIVE 0002081008 Precision IO Group Inc. 9905 NW 17TH STREET BUILDING 1 MIAMI FL FLORIDA 33172 305-913-2400 DELAWARE Quantum Surgical Inc Corporation true Christophe Sibillin 9905 NW 17 Street Building 1 Miami FL FLORIDA 33172 Executive Officer Kurt Azarbarzin 9905 NW 17th Street Building 1 Miami FL FLORIDA 33172 Executive Officer Director Frank Yu 9905 NW 17th Street Building 1 Miami FL FLORIDA 33172 Director Kevin Reilly 9905 NW 17th Street Building 1 Miami FL FLORIDA 33172 Director Joseph DeVivo 9905 NW 17th Street Building 1 Miami FL FLORIDA 33172 Director Chris Geyen 9905 NW 17th Street Building 1 Miami FL FLORIDA 33172 Director Robert Scott 9905 NW 17th Street Building 1 Miami FL FLORIDA 33172 Executive Officer Other Technology Decline to Disclose 06b false 2026-10-02 false true true true false 0 8542758 8542758 0 $6,000,000 of the above amount reflects new money investment; the remaining $2,542,758 reflects options, warrants, or other rights to acquire another security. false 2 0 0 0 false Precision IO Group Inc. Breane Stryker Breane Stryker By POA from Christophe Sibillin, CFO 2026-10-16